Biotech · Private company
Reneo Pharma Ltd
Track this companyFree. Adds Reneo Pharma Ltd to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- MavodelparPhase 2 · Primary Mitochondrial MyopathyClinicalTrials.gov · fetched Nov 12, 2026
- High Dose REN001Phase 1 · Fatty Acid Oxidation DisordersClinicalTrials.gov · fetched Nov 12, 2026
- Low Dose REN001Phase 1 · Fatty Acid Oxidation DisordersClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- An Efficacy and Safety Study of 24 Week Treatment With Mavodelpar (REN001) in Primary Mitochondrial Myopathy PatientsPHASE2 · COMPLETED · started May 21, 2021ClinicalTrials.gov NCT04535609 · fetched Nov 12, 2026
- A Prospective Study of the Disease Characteristics of Adult Patients With Long Chain Fatty Acid Oxidation DisordersCOMPLETED · started Jan 15, 2021ClinicalTrials.gov NCT04482049 · fetched Nov 12, 2026
- A Phase 1b Study of the Safety of REN001 in Patients With Fatty Acid Oxidation DisordersPHASE1 · COMPLETED · started Apr 4, 2019ClinicalTrials.gov NCT03833128 · fetched Nov 12, 2026